Overview
Koh Furugaki practices practicing medicine in Yokohama, Japan.
His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
He is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Koh Furugaki
Is Koh Furugaki a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Koh Furugaki is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Koh Furugaki participate in research or clinical trials?
Yes. Koh Furugaki has published 16 articles and abstracts on conditions like Lung Cancer. You can view a list of Koh Furugaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerMr. Furugaki isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung CancerMr. Furugaki isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Furugaki isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).